Skip to main content
. 2021 Mar 25;26(7):1839. doi: 10.3390/molecules26071839

Figure 3.

Figure 3

(A,B) The effects of MVC on IRF4- and GATA3-producing CD8+ T cells were analyzed through flow cytometry in the spleen. The expression levels of GATA3 mRNA (C) and protein (D) were analyzed by RT-PCR and western blot, respectively, in knee tissues from MVC-treated mice. (E) Representative dot plots of one mouse from each group. Normal control (NC) mice received 1% (v/v) DMSO in saline and MVC (50 mg/kg) intraperitoneally (ip) daily from days 21 to 35. CIA mice were treated with MVC (50 mg/kg) ip after the second immunization. The level of significance was set at * p < 0.05 compared with the CIA control group. Data are presented as mean ± SD (n = 6).